In ovarian cancer, high mRNA expression of MMP-2, -9, -14 and TIMP-2 was reported in ovarian tumors, and correlated with low survival in patients, indicating that the expression of these genes may act as suitable nominators of survival in advanced-stage patients (32). This evidence concerns the gene TIMP2 and ovarian cancer.